ALX Oncology Holdings Inc (ALXO)
1.515
+0.02
(+1.68%)
USD |
NASDAQ |
Nov 05, 16:00
1.53
+0.02
(+0.99%)
After-Hours: 19:03
ALX Oncology Holdings Price to Book Value: 0.5009 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.4926 |
| November 01, 2024 | 0.4794 |
| October 31, 2024 | 0.4728 |
| October 30, 2024 | 0.4562 |
| October 29, 2024 | 0.4629 |
| October 28, 2024 | 0.4827 |
| October 25, 2024 | 0.486 |
| October 24, 2024 | 0.481 |
| October 23, 2024 | 0.5488 |
| October 22, 2024 | 0.4959 |
| October 21, 2024 | 0.4959 |
| October 18, 2024 | 0.4893 |
| October 17, 2024 | 0.4992 |
| October 16, 2024 | 0.5158 |
| October 15, 2024 | 0.5158 |
| October 14, 2024 | 0.5124 |
| October 11, 2024 | 0.5091 |
| October 10, 2024 | 0.4761 |
| October 09, 2024 | 0.5356 |
| October 08, 2024 | 0.5455 |
| October 07, 2024 | 0.5257 |
| October 04, 2024 | 0.5554 |
| October 03, 2024 | 0.5686 |
| October 02, 2024 | 0.605 |
| October 01, 2024 | 0.6149 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.6017 |
| September 27, 2024 | 0.6513 |
| September 26, 2024 | 0.6182 |
| September 25, 2024 | 0.5984 |
| September 24, 2024 | 0.6447 |
| September 23, 2024 | 0.6579 |
| September 20, 2024 | 0.6844 |
| September 19, 2024 | 0.7174 |
| September 18, 2024 | 0.7075 |
| September 17, 2024 | 0.7207 |
| September 16, 2024 | 0.7207 |
| September 13, 2024 | 0.734 |
| September 12, 2024 | 0.7075 |
| September 11, 2024 | 0.7207 |
| September 10, 2024 | 0.7141 |
| September 09, 2024 | 0.6943 |
| September 06, 2024 | 0.6315 |
| September 05, 2024 | 0.6579 |
| September 04, 2024 | 0.6811 |
| September 03, 2024 | 0.7075 |
| August 30, 2024 | 0.767 |
| August 29, 2024 | 0.7604 |
| August 28, 2024 | 0.7736 |
| August 27, 2024 | 0.8232 |
| August 26, 2024 | 0.8497 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4562
Minimum
Oct 30 2024
16.53
Maximum
Dec 10 2020
3.323
Average
2.088
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.326 |
| Neurocrine Biosciences Inc | 4.525 |
| Eton Pharmaceuticals Inc | 15.95 |
| Verve Therapeutics Inc | 0.9840 |
| Immuneering Corp | 0.8855 |
Price to Book Value Related Metrics
| PS Ratio | 19.93 |
| Price | 1.515 |
| Earnings Yield | -239.6% |
| Market Cap | 79.80M |